Shanghai, China

Feifei Cui

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Feifei Cui in Antibody Therapeutics

Introduction

Feifei Cui, based in Shanghai, China, is a renowned inventor with a focus on innovative therapeutic solutions in the field of immunology. With a growing portfolio that includes three patents, Cui has made significant contributions to the development of antibody-based treatments, particularly in cancer therapy.

Latest Patents

Cui's latest patents include a fusion molecule that combines a PD-L1 inhibitor with a human IL-7 protein or fragment thereof. This innovative approach offers synergistic anti-tumor effects, which may enhance the efficiency of cancer treatments. Additionally, he has contributed to the field of human PD-L1 antibodies, providing comprehensive details on full human anti-PD-L1 antibodies and fragments. These antibodies are designed to include specific variable regions selected from various sequence groups. They hold promise for treating and diagnosing diseases, including cancer and infectious diseases, thereby showcasing Cui's commitment to advancing medical science through his inventions.

Career Highlights

Feifei Cui currently works with I-Mab Biopharma US Limited, a company dedicated to developing innovative therapies. His work has positioned him as a key player in the biotechnology landscape, leveraging his expertise in antibody design and biopharmaceutical development to pave the way for new therapeutic modalities.

Collaborations

Cui collaborates closely with esteemed colleagues including Lei Fang and Zhengyi Wang, enhancing the collective expertise and innovation within their team. Their combined efforts are directed towards advancing the science of antibody therapeutics, illustrating the importance of collaboration in scientific research and development.

Conclusion

In conclusion, Feifei Cui's inventive work is making a profound impact on the field of antibody therapeutics. His latest patents reflect his innovative spirit and dedication to improving healthcare outcomes. With ongoing collaboration and research, Cui continues to push the boundaries of medical science, promising exciting advancements in the treatment of cancer and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…